
Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
News Center
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
FOSI INTERNATIONAL CO., LIMITED
ARK Wealth Management (A member firm of Noah Holdings Limited)
Peninsula Merchandising Limited